Administration of Kisspeptin in Patients With Hyperprolactinemia
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The goal of this project is to explore the use of exogenous pulsatile kisspeptin as a
therapeutic alternative for patients with hyperprolactinemia who are intolerant to current
therapies.
Funding Source - FDA OOPD